Latest News

Clinical Trial Deaths in Top Cancer News of the Week
Top news of the week in oncology and cancer drug development.
The finalized rule will improve payment for care relating to chronic diseases, mental health, and cognitive impairment.
Newly developed technology maps HIV inserts across the human genome.
Distinct subsets of synovial fibroblasts in rheumatoid arthritis development identified.
Top news of the week on Specialty Pharmacy Times.
Medical marijuana may fall under specialty pharmacy in the future.
The new method makes breast imaging less risky, and can lessen false-positive readings.
Around 14 million people have HIV worldwide – yet an estimated 40% don’t know they’re infected.


Biosimilars and Follow-on Biologics: A Pharmacist Opportunity
Health care practitioners need to prepare for myriad questions regarding biosimilars and follow-on biologic drugs as they enter the market.
PCSK9 inhibitors are among the most significant tools targeting high cholesterol to arrive since the first statins were approved by the FDA.
How well are we using the longest lever available to affect hundreds of billions of dollars in wasted health care spending?
Artificial intelligence has evolved to the point that it can significantly augment the work done by physicians, pharmacists, and health coaches.

Featured Company Profile

MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy


John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how specialty stakeholders can accurately encapsulate the high volume of data they produce to improve operations.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses the implications of the Medicare Home Infusion Site of Care Act for specialty pharmacy stakeholders.

Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty stakeholders will need to alter current patient management programs as new drugs transform the treatment of diseases into more manageable conditions.

John Campo, vice president of Specialty Pharmacy Trade Relations and Contracting at Managed Health Care Associates, discusses optimal use of data analytics in specialty pharmacy.

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2016
Intellisphere, LLC. All Rights Reserved.